CNBC
14 Sept 2026, 07:00 UTC · 2h ago
Verdict
Headline takes no side. We score LLY +0.50 across five claims.
Our read: bullish.
LLY score
+0.50
More positive than 71% of ticker scores this week
Price reaction
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen
What the story claims
5 claims · scored −1 bearish … +1 bullish
Novo Nordisk trails Eli Lilly significantly in obesity drug market share, holding 38.8% compared to Lilly's 60.9% as of Q2.
More negative than 91% of claims this week
Novo Nordisk has scrapped three clinical trials for an experimental cardiovascular drug.
More negative than 80% of claims this week
Continue reading
5 related stories
Top 2 movers · tap to explore
The oral version of Wegovy has seen a successful launch, surpassing 3 million prescriptions as of June.
More positive than 66% of claims this week
Novo Nordisk will detail business strategy changes during its Capital Markets Day on September 21.
So whatInvestors will view this as a catalyst for potential pivots to regain market share and growth.
More positive than 55% of claims this week
The company is rebranding to 'Novo' and updating its corporate culture to better compete in the direct-to-consumer market.
Near neutral — 98% of claims this week are stronger
Which stocks this story touches
More positive than 71% of ticker scores this week
The company is cited as the market leader in obesity drugs with a dominant 60.9% market share compared to its rival.
More negative than 72% of ticker scores this week
The company is rebranding and updating culture to combat loss of market share, scrapped drug trials, and a 15% share price drop.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The Motley Fool
11h ago
Price reaction
Expected +0.50Actual —
LLY hasn't traded since this ran. Last close $1115.25 (Sep 11); the reaction starts at the next open.
LLY chart →
